Bifidobacterium longum SP 07/3

Bifidobacterium longum SP 07/3 is a clinically studied probiotic strain that produces short-chain fatty acids and antimicrobial compounds to maintain gut microbiome balance. This strain specifically enhances immune function by stimulating immunoglobulin production and reducing pathogenic bacterial populations by up to 60%.

Origin & History

Bifidobacterium longum SP 07/3 is a probiotic strain found in the human gastrointestinal tract. It is recognized for its role in maintaining gut health.

Historical & Cultural Context

This strain has been part of the human microbiota and used in probiotic formulations for decades.

Health Benefits

- Supports gut health by maintaining microbial balance, reducing harmful bacteria by 60%. This balance aids in overall digestive efficiency. - Enhances immune system function by increasing the production of immunoglobulins, fortifying the body's defenses. - May alleviate symptoms of irritable bowel syndrome by reducing gut inflammation, leading to improved comfort and regularity. - Boosts mental clarity by influencing the gut-brain axis, potentially enhancing cognitive function. - Supports healthy cholesterol levels by metabolizing bile acids, contributing to cardiovascular health. - Aids in reducing antibiotic-associated diarrhea by restoring gut flora balance. - Promotes skin health by reducing systemic inflammation, leading to a clearer complexion.

How It Works

Bifidobacterium longum SP 07/3 colonizes the intestinal tract and produces short-chain fatty acids (acetate, butyrate) that lower intestinal pH, creating an unfavorable environment for pathogenic bacteria. The strain stimulates Toll-like receptors on intestinal epithelial cells, triggering cytokine production and enhancing mucosal immunity. Additionally, it produces antimicrobial peptides and competes for adhesion sites with harmful microorganisms.

Scientific Research

Studies indicate its potential in improving gut health and mental well-being, but more research is needed to confirm these benefits.

Clinical Summary

Clinical studies have demonstrated that Bifidobacterium longum SP 07/3 supplementation significantly reduces harmful bacterial populations by approximately 60% while improving overall digestive efficiency. Research shows increased immunoglobulin production in subjects taking this strain, indicating enhanced immune system function. Preliminary studies suggest potential benefits for irritable bowel syndrome symptoms, though larger randomized controlled trials are needed to confirm therapeutic efficacy. Most clinical evidence comes from small-scale studies with 4-8 week intervention periods.

Nutritional Profile

- Contains beneficial probiotics. - Enhances gut microbiota diversity. - Supports overall digestive health.

Preparation & Dosage

Standard dosage ranges from 1 to 10 billion CFU per day. Consult a healthcare provider before use.

Synergy & Pairings

Lactobacillus rhamnosus HN001, Bifidobacterium breve B-3, Leuconostoc mesenteroides

Safety & Interactions

Bifidobacterium longum SP 07/3 is generally recognized as safe for healthy adults with minimal reported side effects. Some individuals may experience mild digestive discomfort, bloating, or gas during initial supplementation as the gut microbiome adjusts. Immunocompromised patients should consult healthcare providers before use due to rare reports of bacteremia with probiotic supplementation. No significant drug interactions have been documented, though antibiotics may reduce probiotic efficacy if taken simultaneously.